These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3124642

  • 1. Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.
    Kawahara E, Oda Y, Ooi A, Katsuda S, Nakanishi I, Umeda S.
    Am J Surg Pathol; 1988 Feb; 12(2):115-20. PubMed ID: 3124642
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The intermediate filament complement of the spectrum of nerve sheath neoplasms.
    Gould VE, Moll R, Moll I, Lee I, Schwechheimer K, Franke WW.
    Lab Invest; 1986 Oct; 55(4):463-74. PubMed ID: 3531717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glial fibrillary acidic protein (GFAP) immunoreactivity in peripheral nerve sheath tumors.
    Memoli VA, Brown EF, Gould VE.
    Ultrastruct Pathol; 1984 Oct; 7(4):269-75. PubMed ID: 6543600
    [Abstract] [Full Text] [Related]

  • 6. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
    Giangaspero F, Fratamico FC, Ceccarelli C, Brisigotti M.
    Appl Pathol; 1989 Oct; 7(2):134-44. PubMed ID: 2471540
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical study of Pacinian corpuscles using monoclonal antibodies for neurofilament protein, glial fibrillary acidic protein and S-100 protein.
    Vega JA, Dubovy P, del Valle-Soto ME, Hernandez LC, Perez-Casas A, Malinovsky L.
    Cell Mol Biol; 1989 Oct; 35(6):627-33. PubMed ID: 2516781
    [Abstract] [Full Text] [Related]

  • 8. GFA protein reactivity in nerve sheath tumors: a polyvalent and monoclonal antibody study.
    Stanton C, Perentes E, Collins VP, Rubinstein LJ.
    J Neuropathol Exp Neurol; 1987 Nov; 46(6):634-43. PubMed ID: 3309191
    [Abstract] [Full Text] [Related]

  • 9. [Clinical and pathologic features of gastric schwannoma].
    Wang ZB, Shi HY, Yuan J, Chen W, Wei LX.
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):97-101. PubMed ID: 22455885
    [Abstract] [Full Text] [Related]

  • 10. The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.
    Nascimento AF, Fletcher CD.
    Am J Surg Pathol; 2007 Sep; 31(9):1363-70. PubMed ID: 17721192
    [Abstract] [Full Text] [Related]

  • 11. An immunohistochemical study of canine tissues with vimentin, desmin, glial fibrillary acidic protein, and neurofilament antisera.
    Vos JH, van den Ingh TS, Misdorp W, Ramaekers FC, van Mil FN, de Neijs M.
    Zentralbl Veterinarmed A; 1989 Oct; 36(8):561-75. PubMed ID: 2515691
    [Abstract] [Full Text] [Related]

  • 12. S-100 protein and glial fibrillary acidic protein (GFAP) in experimentally induced and spontaneous tumours of peripheral nerves in BDVI rats. Light microscopic and immunohistochemical study.
    Turusov VS, Cabral JP.
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):343-53. PubMed ID: 7894246
    [Abstract] [Full Text] [Related]

  • 13. Transient modulation of Schwann cell antigens after peripheral nerve transection and subsequent regeneration.
    Neuberger TJ, Cornbrooks CJ.
    J Neurocytol; 1989 Oct; 18(5):695-710. PubMed ID: 2515258
    [Abstract] [Full Text] [Related]

  • 14. [Immunohistochemical study of developing rat embryo--localization of vimentin, GFAP, neurofilament protein within rat embryo central nervous system].
    Kamada H, Itoh T, Hyogo T, Satoh S, Ogasawara T, Fujiwara H, Ara S, Hotta T, Suematsu K, Nakamura J.
    No To Shinkei; 1988 Mar; 40(3):211-8. PubMed ID: 3134930
    [Abstract] [Full Text] [Related]

  • 15. Postnatal development of glial fibrillary acidic protein, vimentin and S100 protein in monkey visual cortex: evidence for a transient reduction of GFAP immunoreactivity.
    Missler M, Eins S, Böttcher H, Wolff JR.
    Brain Res Dev Brain Res; 1994 Oct 14; 82(1-2):103-17. PubMed ID: 7842498
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of an established human glioma cell line, KNS-42.
    Takeshita I, Takaki T, Kuramitsu M, Nagasaka S, Machi T, Ogawa H, Egami H, Mannoji H, Fukui M, Kitamura K.
    Neurol Med Chir (Tokyo); 1987 Jul 14; 27(7):581-7. PubMed ID: 2448680
    [No Abstract] [Full Text] [Related]

  • 17. Immunoreactivity of bovine schwannomas.
    Nielsen AB, Jansen ECL, Leifsson PS, Jensen HE.
    J Comp Pathol; 2007 Nov 14; 137(4):224-230. PubMed ID: 17888938
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical localization of intermediate filament and S-100 proteins in several non-endocrine cells of the human pituitary gland.
    Marin F, Boya J, Lopez-Carbonell A, Borregón A.
    Arch Histol Cytol; 1989 Jul 14; 52(3):241-8. PubMed ID: 2476166
    [Abstract] [Full Text] [Related]

  • 19. Vimentin and glial fibrillary acidic protein expression in relation to neoplastic cell differentiation in glial tumors.
    Pazanin L, Poljaković Z, Palić J.
    Neurol Croat; 1992 Jul 14; 41(4):191-203. PubMed ID: 1463804
    [Abstract] [Full Text] [Related]

  • 20. Aberrant axon neurofilaments in schwannomas associated with phacomatoses.
    Wechsler J, Lantieri L, Zeller J, Voisin MC, Martin-Garcia N, Wolkenstein P.
    Virchows Arch; 2003 Dec 14; 443(6):768-73. PubMed ID: 14508685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.